Printed From BioPortfolio.com

Taiwan Liposome Forms China Commercialization JV with Jixi Biotech

02:56 EST 23 Jan 2018 | ChinaBio Today

Taiwan Liposome will form a joint venture with Jixi Biotechnology to market Taiwan Liposome's products in China. JiXi will make an investment of "millions of dollars" in a Hong Kong subsidiary of Taiwan Liposome in exchange for a minority stake in the company. Taiwan Liposome said it would use Jixi Biotech's experience and resources in mainland China to promote and sell their drugs more efficiently. More details....

Stock Symbol: (TT: 4152)

Share this with colleagues:

Original Article: Taiwan Liposome Forms China Commercialization JV with Jixi Biotech

More From BioPortfolio on "Taiwan Liposome Forms China Commercialization JV with Jixi Biotech"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches